GLAND PHARMA LTD.● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO GLAND PHARMA LTD.● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO
Live GMP
Back to IPOs
Gland Pharma Ltd.

Gland Pharma Ltd.

NSE & BSE · Mainboard IPO
Listed NSE & BSE Mainboard Live Chart
Issue Price
₹1,500
₹1,500
GMP (Grey Market)
NIL
Unofficial data only
Est. Listing Price
₹1,500
Based on GMP
Min. Investment
₹15,000
1 lot × 10 shares
Subscribed
1.00x
Over-subscribed
IPO Details
Open Date
09 Nov 2020
Close Date
11 Nov 2020
Allotment
17 Nov 2020
Listing Date
20 Nov 2020
Exchange
NSE & BSE
Price Band
₹1,500
Listing Price
See chart
Allotment Status
Price Band
₹1,500
Per share
Face Value
₹1 per share
 
Lot Size
10 Shares
per lot
Issue Size
4,31,96,968 shares (aggregating up to ₹6,479.55 Cr)
Total offering
Issue Type
Bookbuilding IPO
 
Min Investment
₹15,000
1 lot
Pre-IPO Holding
15,49,49,490 shares
Promoters
Post-IPO Holding
16,32,82,823 shares
Promoters
UPI Deadline
2020-11-11
Mandate
Anchor AllotmentFri, 06 Nov 2020
Basis of AllotmentTue, 17 Nov 2020
Refund InitiationWed, 18 Nov 2020
Demat CreditThu, 19 Nov 2020
Listing DayFri, 20 Nov 2020
UPI Mandate Deadline2020-11-11
Sale TypeFresh Capital-cum-Offer for Sale
Fresh Issue Shares83,33,333 shares (aggregating up to ₹1,250.00 Cr)
Offer for Sale3,48,63,635 shares of ₹1 (aggregating up to ₹5,229.55 Cr)
QIB Quota50% of Net Issue
HNI / NII Quota15% of Net Issue
Retail Quota35% of Net Issue
Check AllotmentClick here →
Subscription Rate Final
Gland Pharma Ltd. IPO subscribed 1.00 times overall. Retail: 1.00x. QIB: 1.00x. NII: 1.00x. By 11 Nov 2020.
QIB
1.00x
Over
NII/HNI
1.00x
Over
Retail
1.00x
Over
Total
1.00x
Over
Category Subscription Shares Offered % of Total Amount (₹Cr)
QIB
Over 1.00x
NII / HNI
Over 1.00x
Retail
Over 1.00x
Total 1.00x
43,196,968
100% ₹6,479.55
IPO Shares Offered
Gland Pharma Ltd. IPO total issue size: ₹6,479.55 Cr.
CategoryShares OfferedAmount (₹Cr)Size (%)
Total 43,196,968 ₹6,479.55
100.00%
* Based on upper price band ₹1,500 per share
Lot Size & Investment
Lot Size
10
Shares per Lot
Issue Price
₹1,500.00
Upper Band
Min Investment
₹15,000
1 Lot
ApplicationLotsSharesAmount
Retail (Min — 2 Lots)220₹30,000
Retail (Max — 13 Lots)13130₹195,000
S-HNI (Min — 14 Lots)14140₹210,000
B-HNI (Min — 68 Lots)68680₹1,020,000
* Issue Price ₹1,500 × Lot Size 10 shares
IPO Schedule
Anchor
06 Nov 2020
✓ Done
IPO Open
09 Nov 2020
✓ Done
IPO Close
11 Nov 2020
✓ Done
Allotment
17 Nov 2020
✓ Done
Refunds
18 Nov 2020
✓ Done
Demat Credit
19 Nov 2020
✓ Done
Listing Day
20 Nov 2020
✓ Done
Gland Pharma Ltd. — Live Price LIVE
₹1,500.00
INR · BSE
Fetching…
vs Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading…
Chart Not Available
Try again 2–3 days after listing.
Issue ₹1,500.00 Live Price
About Gland Pharma Ltd.
Gland Pharma Ltd, the Hyderabad-based company is one of the fastest-growing generic injectable companies. It manufactures a diversified range of high-quality complex injectables. The company offers products like sterile injectables, oncology, and ophthalmics, complex injectables (peptides, suspensions, hormonal products, long-acting injectables), NCE-1s, First-to-File products, etc.The company follows a B2B model to sell its products in more than 60 countries including the US, Canada, Australia, India, Europe, etc. Leading pharma companies i.e. Sagent Pharmaceuticals, Apotex Inc. Athnex Pharmaceutical Division, LLC, Fresenius Kabi USA, LLC, etc. are some of the key customers.It has 7 robust manufacturing units in India comprising 4 finished formulations facilities, 22 production lines, and 3 APIs.Company StrengthsThe extensive product portfolio of complex injectables.Diversified B2B model with a targeted B2C model in India.Strong manufacturing capabilities.Robust financial track record.Experienced and qualified managerial team.
Objects of the Issue
1
1 Funding incremental working capital requirements of our Company
2
2 Funding capital expenditure requirements of our Company
3
3 General corporate purposes
Gland Pharma Ltd. Financials (Amount in Crore)
Revenue from Operations
₹2,129.8
31-Mar-19
₹2,772.4
31-Mar-20
₹916.3
30-June-20
Profit After Tax (PAT)
₹451.9
31-Mar-19
₹772.9
31-Mar-20
₹313.6
30-June-20
Particulars30-June-2031-Mar-2031-Mar-19
Revenue from Operations 916.29 2772.41 2129.77
EBITDA N/A N/A N/A
Profit After Tax (PAT) 313.59 772.86 451.86
Net Worth N/A N/A N/A
Total Assets 4691.27 4086.04 3523.55
Reserves & Surplus N/A N/A N/A
Borrowings N/A N/A N/A
EBITDA Margin (%) N/A
PAT Margin (%) N/A
Issue Structure & Shareholding
Total Shares Offered4,31,96,968 (100.00%)
Net Offer to PublicN/A
Reserved for Market MakerN/A
Pre-Issue Promoter Holding15,49,49,490 shares
Post-Issue Promoter Holding16,32,82,823 shares
P/BV RatioN/A
RoEN/A
RoCEN/A
Debt / EquityN/A
Script CodeN/A
Registrar & Lead Managers
Book Running Lead Managers
Citigroup Global Markets India Pvt.Ltd.
Haitong Securities India Pvt.Ltd.
Kotak Mahindra Capital Co.Ltd.
Nomura Financial Advisory & Securities (India) Pvt.Ltd.
GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.
IPO Subscription FAQs
How much Gland Pharma Ltd. IPO subscribed?

Gland Pharma Ltd. IPO is subscribed 1.00 times by Nov 11, 2020. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.

Investor CategorySubscription
Qualified Institutional (QIB)1.00x
Non Institutional (NII/HNI)1.00x
Retail Individual1.00x
Total Subscription1.00x
What is Gland Pharma Ltd. IPO retail subscription status?

The Gland Pharma Ltd. IPO retail category is subscribed 1.00 times as of 11 Nov 2020. The retail portion is oversubscribed.

How to subscribe Gland Pharma Ltd. IPO?

Subscribe via your broker app using ASBA or UPI. Opens 09 Nov 2020 and closes 11 Nov 2020. Min investment: ₹15,000 (1 lot = 10 shares). UPI mandate: 2020-11-11.

How many times Gland Pharma Ltd. IPO subscribed?

The Gland Pharma Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.

How to check Gland Pharma Ltd. IPO allotment?

Check allotment on the registrar website (MUFG Intime India Pvt.Ltd.) at https://linkintime.co.in/Initial_Offer/public-issues.html. Enter your PAN, application number or DP/Client ID. Allotment date: 17 Nov 2020. Refunds: on 18 Nov 2020.

When Gland Pharma Ltd. IPO will be listed?

The Gland Pharma Ltd. IPO listing date is 20 Nov 2020, Friday. Listed on: NSE & BSE. Issue price: ₹1,500. Estimated listing: ₹1,500. GMP: NIL.

When Gland Pharma Ltd. IPO close?

The Gland Pharma Ltd. IPO closes on 11 Nov 2020, Wednesday. UPI mandate: 2020-11-11. Allotment: 17 Nov 2020. Listing: 20 Nov 2020.